The decision puts mass litigation against the drugmaker back on course by overturning a ruling that the science was unreliable.
Source link
The decision puts mass litigation against the drugmaker back on course by overturning a ruling that the science was unreliable.
Source link
© 2026 Agentially - Navigating shifting sovereignties and global risk .
© 2026 Agentially - Navigating shifting sovereignties and global risk .